Australian Medical Association Alleges distressing incidents of patient harm” in South Australia, specifically due to “inappropriate prescribing practices”.  But Does Not Say Who Where What | Cannabis Law Report | Where to order Skittles Moonrock online

The AMA is continuing its state-by-state critique of the medicinal cannabis industry, citing concerns about “distressing incidents of patient harm” in South Australia, specifically due to “inappropriate prescribing practices”.

Here’s a more detailed breakdown:

• AMA’s Concerns:

  The Australian Medical Association (AMA) has publicly expressed concerns about the medicinal cannabis industry, claiming it is aware of “distressing incidents of patient harm”.

• Focus on South Australia:

  The AMA’s criticism is specifically focused on South Australia, where they claim to have identified “inappropriate prescribing practices”.

• “Inappropriate Prescribing Practices”:

  The AMA has not elaborated on what specific prescribing practices they consider inappropriate.

• State-by-State Approach:

  The AMA’s criticism appears to be a state-by-state approach, with concerns being raised in South Australia, and potentially other states in the future.

• Cannabiz Article:

  An article on Cannabiz.com.au reports that the AMA is renewing its attack on the industry, with South Australia now raising concerns.